Advertisement
Advertisement
MSLE
M
Satellos Bioscience Inc. Common Stock
8.58
USDSponsored
-1.42
-14.16%
Mar 12, 16:00 UTC -4
Closed
After-Market
8.56
-0.02
-0.28%
MSLE Earnings Reports
Positive Surprise Ratio
MSLE beat 0 of 1 last estimates.
0%
Next Report
Date of Next Report
Apr 01, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.21
Implied change from Q3 25 (Revenue/ EPS)
--
/-57.14%
Implied change from Q4 24 (Revenue/ EPS)
--
/+320.00%
Satellos Bioscience Inc. Common Stock earnings per share and revenue
On Nov 14, 2025, MSLE reported earnings of -0.49 USD per share (EPS) for Q3 25, missing the estimate of -0.48 USD, resulting in a -0.49% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference.
Looking ahead to Q4 25, -- analysts forecast an EPS of -0.21 USD, with revenue projected to reach -- USD, implying an decrease of -57.14% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
BrightSpring Health Services, Inc. Tangible Equity Unit
Report Date
Feb 27, 2026 For Q4 25
Estimate
$0.35
Actual
$0.33
Surprise
-7.56%
MSC Income Fund, Inc.
Report Date
Feb 26, 2026 For Q4 25
Estimate
$0.37
Actual
$0.37
Surprise
-0.03%
AH Realty Trust, Inc.
Report Date
Feb 26, 2026 For Q4 25
Estimate
$0.15
Actual
$0.06
Surprise
-61.93%
PureCycle Technologies, Inc. Unit
Report Date
Feb 26, 2026 For Q4 25
Estimate
-$0.25
Actual
-$0.14
Surprise
+44.18%
OFS Capital Corporation 4.95% Notes due 2028
Report Date
Mar 02, 2026 For Q4 25
Estimate
$0.23
Actual
$0.20
Surprise
-13.90%
SuRo Capital Corp. 6.00% Notes due 2026
Report Date
Mar 09, 2026 For Q4 25
Estimate
-$0.11
Actual
-$0.62
Surprise
-428.56%
WhiteHorse Finance, Inc. 7.875% Notes due 2028
Report Date
Mar 02, 2026 For Q4 25
Estimate
$0.27
Actual
$0.28
Surprise
+1.45%
OFS Credit Company, Inc. 5.25% Series E Term Preferred Stock Due 2026
Report Date
Mar 05, 2026 For Q1 26
Estimate
$0.22
Actual
$0.32
Surprise
+42.60%
Imperial Petroleum Inc. 8.75% Series A Cumulative Redeemable Perpetual Preferred Shares
Report Date
Mar 06, 2026 For Q4 25
Estimate
$0.34
Actual
$0.35
Surprise
+0.92%
FAQ
What were Satellos Bioscience Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Satellos Bioscience Inc. Common Stock reported EPS of -$0.49, missing estimates by -0.49%, and revenue of $0.00, 0% as expectations.
How did the market react to Satellos Bioscience Inc. Common Stock's Q3 2025 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Satellos Bioscience Inc. Common Stock expected to report next?
The next earning report is scheduled for Apr 01, 2026.
What are the forecasts for Satellos Bioscience Inc. Common Stock's next earnings report?
Based on --
analysts, Satellos Bioscience Inc. Common Stock is expected to report EPS of -$0.21 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement